```html

Oophoritis (Inflammation of the Ovary)

What is Oophoritis?

Oophoritis is the medical term for inflammation of one or both ovaries. The condition can be acute or chronic and may involve infection, autoimmune activity, or irritation from nearby pelvic structures. Because the ovaries are small, hormone‑producing glands deep within the pelvis, inflammation often co‑exists with other pelvic disorders such as salpingo‑oophoritis (inflammation of the fallopian tubes) or pelvic inflammatory disease (PID). The term is most commonly used in obstetrics‑gynecology literature and in surgical pathology reports.

In most cases the inflammation is a response to an infection, but it can also be sterile (non‑infectious) and result from autoimmune disease, endometriosis, or even a reaction to a foreign body. Early recognition is important because persistent inflammation can damage ovarian tissue, affect hormone production, and compromise fertility.

Common Causes

The following conditions are the most frequent precipitating factors for oophoritis. Some are infectious, others are inflammatory or iatrogenic.

• Pelvic Inflammatory Disease (PID) – bacterial infection spreading from the cervix or uterus to the ovaries.
• Sexually transmitted infections (STIs) – especially Chlamydia trachomatis and Neisseria gonorrhoeae.
• Post‑operative infection – after gynecologic surgery (e.g., oophorectomy, cystectomy) or laparoscopic procedures.
• Endometriosis – ectopic endometrial tissue can provoke chronic inflammation and adhesions around the ovaries.
• Autoimmune disorders – systemic lupus erythematosus, Sjögren’s syndrome, or vasculitis may target ovarian tissue.
• Tuberculosis – genitourinary TB can involve the ovaries, especially in endemic regions.
• Intra‑abdominal abscess or diverticulitis – spread of infection from nearby bowel can reach the ovary.
• Radiation or chemotherapy – tissue injury may produce sterile inflammation.
• Foreign body reaction – retained surgical sponges, sutures, or IUD fragments.
• Rare parasitic infections – e.g., pelvic echinococcosis.

Associated Symptoms

Oophoritis rarely occurs in isolation. The most common accompanying signs and symptoms include:

• Lower abdominal or pelvic pain, often unilateral but can be bilateral.
• Fever or chills (suggesting infection).
• Abnormal vaginal discharge (purulent or malodorous).
• Irregular menstrual bleeding or spotting.
• Nausea, vomiting, or loss of appetite.
• Dyspareunia (painful intercourse).
• Frequent urinary urgency or dysuria when inflammation irritates the bladder.
• Generalized feelings of fatigue or malaise.

When to See a Doctor

Because ovarian inflammation can progress rapidly, you should seek medical attention promptly if you notice any of the following:

• Sudden, severe pelvic pain that does not improve with rest.
• Fever higher than 100.4°F (38°C) accompanied by abdominal pain.
• Purulent or foul‑smelling vaginal discharge.
• Persistent vomiting, inability to keep fluids down, or signs of dehydration.
• Rapidly worsening pain after a recent gynecologic procedure.
• Unexplained changes in menstrual cycle combined with pain.
• Signs of pregnancy (positive test) together with pelvic pain – this could indicate an ectopic pregnancy or tubo‑ovarian abscess, both emergencies.

If you are pregnant, have a known immune deficiency, or have a history of severe PID, err on the side of earlier evaluation.

Diagnosis

Diagnosing oophoritis involves a combination of history‑taking, physical examination, imaging, and laboratory studies.

Clinical Evaluation

• History – sexual activity, recent surgeries, contraceptive use, prior PID or endometriosis.
• Physical exam – bimanual pelvic exam to assess tenderness, masses, and cervical motion tenderness (a classic PID sign).

Laboratory Tests

• Complete blood count (CBC) – leukocytosis suggests infection.
• Erythrocyte sedimentation rate (ESR) or C‑reactive protein (CRP) – markers of inflammation.
• Urine pregnancy test – rules out ectopic pregnancy.
• Vaginal swabs for GC/*CT nucleic‑acid amplification tests (NAATs).
• Blood cultures if systemic infection is suspected.
• Serologic testing for tuberculosis or autoimmune markers when indicated.

Imaging Studies

• Transvaginal ultrasound – first‑line; looks for enlarged ovaries, adnexal masses, or fluid collections.
• Pelvic MRI – provides detailed soft‑tissue contrast, useful for differentiating an abscess from endometrioma.
• CT scan – reserved for complicated cases with suspected intra‑abdominal spread.

Laparoscopy

When non‑invasive tests are inconclusive, diagnostic laparoscopy offers direct visualization, enables drainage of an abscess, and allows tissue biopsies for microbiology and pathology.

Treatment Options

Therapy is directed at the underlying cause, relieving symptoms, and preserving ovarian function.

Antibiotic Therapy (Infectious Causes)

• Empiric regimen (based on CDC PID guidelines):
  • Ceftriaxone 250 mg IM single dose
  • Doxycycline 100 mg orally twice daily for 14 days
  • Add Metronidazole 500 mg orally twice daily if bacterial vaginosis or anaerobes are suspected.
• Adjust antibiotics according to culture and sensitivity results.
• Hospitalization and IV antibiotics (e.g., cefoxitin + doxycycline) for severe infection, tubo‑ovarian abscess > 8 cm, or inability to tolerate oral meds.

Management of Non‑Infectious Inflammation

• Endometriosis‑related oophoritis – hormonal suppression (combined oral contraceptives, GnRH agonists, progestins) and surgical excision of endometriomas if large.
• Autoimmune‑mediated – short‑course corticosteroids (prednisone 0.5‑1 mg/kg) after rheumatology consultation; disease‑modifying agents for chronic systemic disease.
• Tuberculous oophoritis – multi‑drug anti‑TB regimen (isoniazid, rifampin, pyrazinamide, ethambutol) for at least 6 months.

Surgical Interventions

• Drainage of a tubo‑ovarian abscess via laparoscopy or image‑guided needle aspiration.
• Ovarian cystectomy or oophorectomy when necrotic tissue is present or fertility preservation is not feasible.
• Adhesiolysis to restore pelvic anatomy after chronic inflammation.

Supportive & Home Care

• Heat packs or warm baths for pain relief.
• Hydration – at least 2 L of water daily unless restricted.
• Over‑the‑counter analgesics (acetaminophen or ibuprofen) unless contraindicated.
• Sexual abstinence until treatment is complete and symptoms resolve.
• Follow‑up appointments to monitor response and repeat imaging if needed.

Prevention Tips

While not all cases are preventable, risk can be markedly reduced through the following measures:

• Practice safe sex: consistent condom use and limiting the number of sexual partners.
• Get regular STI screening—annual testing for sexually active women under 25 or as recommended.
• Promptly treat any diagnosed pelvic infection to prevent spread to the ovaries.
• Attend scheduled gynecologic check‑ups, especially if you have a history of endometriosis, PID, or prior pelvic surgery.
• Complete the full course of prescribed antibiotics, even if symptoms improve early.
• Consider HPV vaccination, which reduces the risk of cervical pathology that can predispose to PID.
• Maintain a healthy immune system through balanced nutrition, regular exercise, adequate sleep, and smoking cessation.
• For women undergoing IVF or other assisted reproductive technologies, follow clinic infection‑control protocols closely.

Emergency Warning Signs

Key Take‑aways

Oophoritis is an inflammation of the ovaries most often triggered by infection, but it can also arise from endometriosis, autoimmune disease, or postoperative complications. Prompt recognition of symptoms—especially fever, severe pain, and abnormal vaginal discharge—allows early treatment that can preserve fertility and prevent serious complications such as abscess formation or sepsis. A combination of antibiotics, hormonal therapy, or surgery, tailored to the underlying cause, usually results in full recovery.

References:

1. Mayo Clinic. “Pelvic inflammatory disease (PID).” https://www.mayoclinic.org/diseases‑conditions/pid/diagnosis‑treatment
2. Centers for Disease Control and Prevention. “Sexually transmitted disease treatment guidelines, 2021.” https://www.cdc.gov/std/treatment‑guidelines/default.htm
3. NIH National Institute of Child Health & Human Development. “Endometriosis.” https://www.nichd.nih.gov/health/topics/endometriosis
4. World Health Organization. “Tuberculosis – Genitourinary TB.” https://www.who.int/news‑room/fact‑sheets/detail/tuberculosis
5. Cleveland Clinic. “Tubo‑ovarian abscess.” https://my.clevelandclinic.org/health/diseases/21664‑tubo-ovarian-abscess
6. UpToDate. “Management of pelvic inflammatory disease in non‑pregnant adolescents and adults.” (accessed May 2026).

```